Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 201-205

  Proška, Jan ^a,b   Tuček, Stanislav ^b  

^a Research Institute of Pharmacy and Biochemistry Prague   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

alcuronium; allosteric interaction; eburnamonine; muscarinic receptor, allosteric control; muscarinic receptor, heart; strychnine; vincamine

Indexed keywords

ALCURONIUM; ATROPINE; MUSCARINIC RECEPTOR; RADIOLIGAND; STRYCHNINE; VINBURNINE; VINCAMINE;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SPECIFICITY; HEART ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0038342828     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00169-0     Document Type: Article

References (28)

1. Adams, A., B. Jarrott, B.C. Elmes, W.A. Denny and L.P.G. Wakelin, 1985, Interaction of DNA-intercalating antitumor agents with adrenoceptors, Mol. Pharmacol. 27, 480.
2. Dong, G.Z., K. Kameyama, A. Rinken and T. Haga, 1995a, Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expresssed in baculovirus-infected insect cells, J. Pharmacol. Exp. Ther. 274, 378.
3. Dong, G.Z., T. Haga, H. Itokawa and F. Mizobe, 1995b, Allosteric binding of 9-methoxy-alpha-lapachone and alcuronium to the muscarinic acetylcholine receptor m2 subtype, Biomed. Res. 16, 327.
4. Drago, F., M. Grassi, C. Valerio, F. Spadaro, V. D'Agata and N. Lauria, 1990, Effects of vinburnine on experinmental models of learning and memory impairments, Pharmacol. Biochem. Behav. 37, 53.
5. Ehlert, J., 1988, Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods, Mol. Pharmacol. 33, 187.
6. Hejnová, L., S. Tuček and E.E. El-Fakahany, 1995, Positive and negative allosteric interactions on muscarinic receptors, Eur. J. Pharmacol. 291, 427.
7. Iino, T., M. Katsura and K. Kuriyama, 1993, Effect of vinconate, an indolonaphthyridine derivative, on metabolism and function of cerebral cholinergic neurons in rat, Neurochem. Int. 23, 399.
8. Jakubík, J. and S. Tuček, 1994a, Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium, J. Neurochem. 63, 1932.
9. Jakubík, J. and S. Tuček, 1994b, Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation, Br. J. Pharmacol. 113, 1529.
10. Jakubík, J. and S. Tuček, 1995, Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups, Eur. J. Pharmacol. 289, 311.
11. Jakubík, J., L. Bačáková, E.E. El-Fakahany and S. Tuček, 1995, Subtype specificity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors, J. Pharmacol. Exp. Ther. 274, 1077.
12. Katsura, M., T. Iino and K. Kuriyama, 1993, (±)-Methyl-2,3,3a,4-tetrahydro-1 H-indolo[3,2,1-de][1,5]naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms, J. Pharmacol. Exp. Ther. 267, 192.
13. Koda, H., T. Hashimoto and K. Kuriyama, 1989, Muscarinic receptormediated regulation of OM-853-enhanced dopamine release in striatum of rat, Eur. J. Pharmacol. 162, 501.
14. Lazareno, S. and N.J.M. Birdsall, 1995, Dectection, quantification, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48, 362.
15. Lee, N.H. and E.E. El-Fakahany, 1991, Allosteric antagonists of the muscarinic acetylcholine receptor, Biochem. Pharmacol. 42, 199.
16. Leppik, R.A., R.C. Miller, M. Eck and J.-L. Paquet, 1994, Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor, Mol. Pharmacol. 45, 983.
17. 2+ dependence, Eur. J. Pharmacol. 162, 387.
18. Matsui, H., S. Lazareno and N.J.M. Birdsall, 1995, Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis, Mol. Pharmacol. 47, 88.
19. Proška, J. and S. Tuček, 1994, Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors, Mol. Pharmacol. 45, 709.
20. Proška, J. and S. Tuček, 1995, Competition between positive and negative allosteric effectors on muscarinic receptors, Mol. Pharmacol. 48, 696.
21. Schwarting, A.E., 1977, Dimeric natural compounds with pharmacological activity, in: New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutic Activity, ed. H. Wagner and P.M. Wolff (Springer Verlag, Berlin), p. 197.
22. Spagnoli, A. and G. Tognoni, 1983, 'Cerebroactive' drugs; clinical pharmacology and therapeutic role in cerebrovascular disorders, Drugs 26, 44.
23. Taylor, W.I., 1965, The Pentaceras and the eburnamine (Hunteria)-vincamine alkaloids, in: The Alkaloids: Chemistry and Physiology, ed. R.H.F. Manske (Academic Press, New York, NY), Vol. 8, p. 249.
24. Tuček, S. and J. Proška, 1995, Allosteric modulation of muscarinic acetylcholine receptors, Trends Pharmacol. Sci. 16, 205.
25. Tuček, S., J. Musílková, J. Nedoma, J. Proška, S. Shelkovnikov and J. Vorlíček, 1990, Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors, Mol. Pharmacol. 38, 674.
26. Tuček, S., J. Proška, L. Hejnová and E.E. El-Fakahany, 1995, Allosteric interactions between alcuronium and ligands binding to the classical binding site on cardiac muscarinic receptors, Life Sci. 56, 1009.
27. Van Hijfte, L., V. Zerr, M. Hibert and L.M. Van Giersbergen, 1995, Quaternary ammonium groups are not crucial for the allosteric effect of gallamine on the human m2 muscarinic receptor, Med. Chem. Res. 5, 449.
28. Windholz, M. (ed.), 1983, The Merck Index, 10th edn. (Merck & Co., Rahway, NJ) p. 1428.